Abbott Laboratories: Long-Term Optimism, Short-Term Overvaluation [Seeking Alpha]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Seeking Alpha
Abbott Laboratories is a diversified healthcare company with strong segments, particularly Medical Devices, contributing to steady growth and consistent dividends. ABT's Q2 earnings showed solid performance, with Medical Devices leading organic revenue growth, despite some segments facing challenges including discontinuing products and COVID-19 sales decline. The company authorized a new $7 billion buyback program, reinforcing its commitment to returning cash to shareholders through dividends and share repurchases. While ABT's long-term growth prospects are positive, current valuations appear stretched, leading to a Hold rating in line with cautious market sentiment. Sundry Photography/iStock Editorial via Getty Images Abbott Laboratories ( NYSE: ABT ) is a global-diversified healthcare company that develops, manufactures, and sells healthcare products worldwide. It has four main segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and t
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Christine Poole's Top Picks: CGI, Linde Pic and Microsoft [BNN Bloomberg (Canada)]BNN Bloomberg
- Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever [Yahoo! Finance]Yahoo! Finance
- Company News for Oct 17, 2024 [Yahoo! Finance Canada]Yahoo! Finance Canada
- Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Sanford C. Bernstein from $133.00 to $138.00. They now have an "outperform" rating on the stock.MarketBeat
ABT
Earnings
- 10/16/24 - Beat
ABT
Sec Filings
- 10/21/24 - Form 144
- 10/16/24 - Form 8-K
- 10/1/24 - Form 4
- ABT's page on the SEC website